Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Researchers Produce Stable RNA Nanoparticles

By LabMedica International staff writers
Posted on 01 Feb 2011
The emerging field of RNA nanotechnology received a boost from the recently reported development of RNase- resistant RNA nanoparticles.

Use of RNA as the basis for nanoparticle manufacture has lagged behind the use of DNA largely due to the greater susceptibility of RNA to enzymatic degradation (principally by RNase). More...
However, investigators at the University of Cincinnati (OH, USA) have found a solution to this problem.

They reported in the December 14, 2010, online edition of the journal ACS Nano that chemically modified 2′-F (2′-fluoro) RNA was resistant to RNase digestion. The 2′-F RNA could be incorporated into nanoparticles that retained the RNA's property for correct folding in dimer formation, appropriate structure in pro-capsid binding, and its biological activity in packaging viral DNA and producing infectious viral particles.

The authors concluded that, "They had demonstrated that it is practical to produce RNase-resistant, biologically active, and stable RNA for application in nanotechnology.”

Related Links:

University of Cincinnati




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Thyroid Test
Anti-Thyroid EIA Test
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.